DentinVaccine
DentinVaccine
The Dentin Vaccine project's mission is to explore novel methods to fortify and enhance the durability of dentin, a mineralized tissue found in teeth. The project endeavors to achieve this by employing solute carriers to transport specific inorganic trace minerals into the dentin matrix. The primary aim is to bolster the apatite structure of dentin, thereby increasing its hardness and resilience.
Through the use of solute carriers for delivering inorganic trace minerals, the project aims to optimize the process of cation substitution. This process involves replacing certain calcium ions within the dentin's apatite structure with ions from the delivered trace minerals, with the goal of altering dentin properties to enhance its strength and resistance to decay.
The overarching goal of the Dentin Vaccine project is to develop a potential treatment or intervention capable of fostering healthier and more robust dentin. This could potentially result in improved dental health and greater longevity of teeth.
Importance
The necessity for the Dentin Vaccine product arises from the desire to transition dental care from reactive treatment to proactive prevention. Conventional dental procedures often involve repairing or replacing damaged teeth, which can be costly, time-consuming, and invasive. However, by strengthening dentin with IoTM via the Dentin Vaccine, dental professionals aim to preemptively fortify teeth and prevent common dental issues like decay, fractures, and structural deficiencies.
The Dentin Vaccine product has the potential to revolutionize preventive dentistry by offering a non-invasive, cost-effective, and enduring solution. By enhancing the quality and resilience of dentin, it can decrease the need for extensive dental procedures such as fillings, root canals, or extractions. Additionally, it can lower the risk of tooth decay and fractures, providing patients with enhanced oral health, comfort, and overall well-being.
Moreover, the Dentin Vaccine product seeks to prolong the lifespan of natural teeth, diminishing reliance on dental prosthetics and restorations. This not only enhances smile aesthetics but also preserves the natural dentition and its functional abilities.
In essence, the Dentin Vaccine product is crucial as it signifies a shift in dental care towards prevention over treatment. It addresses the demand for proactive, non-invasive, and sustainable solutions that bolster the structural integrity and longevity of dentin, resulting in improved oral health outcomes and a better quality of life for individuals.
Current progress overview
Milestone Achievements:
Our team has reached significant milestones within the Dentin Vaccine project, securing multiple US patents related to Dentin Vaccine variations and the use of solute carriers for vaccine delivery. These achievements exemplify our dedication to innovation and the advancement of dental research.
Formulation Development and Testing:
A recent accomplishment involves the successful development and testing of diverse Dentin Vaccine formulations. Through meticulous experimentation and analysis, we have pinpointed specific combinations of Ionic Trace Minerals (IoTM) and optimized solute carrier systems that effectively strengthen dentin and enhance its structural integrity. These formulations exhibit promising results in fortifying dentin against decay and fractures.
Advancements in Understanding Mechanisms:
Collaborative efforts have led to significant strides in comprehending the underlying mechanisms of calcium ion substitution and its impact on the physical and chemical properties of dentin. Through in-depth studies and advanced analytical techniques, we have explored critical aspects such as lattice parameter and residual stress, contributing valuable insights to the field and laying the groundwork for future breakthroughs in preventive dentistry.
Commitment to Interdisciplinary Collaboration:
Our team takes pride in fostering interdisciplinary collaboration, bringing together experts from diverse fields including periodontics, engineering, computer science, and materials science. This collaborative approach encourages innovation, shared expertise, and unconventional thinking, proving instrumental in driving the success of our project and generating novel insights into the Dentin Vaccine.
Future Dedication:
Moving forward, we remain dedicated to pushing the boundaries of dental research, advancing the Dentin Vaccine project, and ultimately enhancing oral health outcomes for patients. Our recent achievements underscore our team's unwavering commitment, expertise, and pursuit of excellence in the field of dentistry.
Management Team
Dr. M Ali Saghiri
D.Eng.PhD
Chief Innovative Officer (CINO)
Principal Investigator (PI)
Dr. Hamed Kazerani
PhD
CEO
Alexander Quiroz
Biomedical Masters' Student
BS, MS
Matthew Nekoui
Biomedical Master's Student
Public Relations
Devyani Nath
BS, MS
Lab Manager
Scientific Team
Dr. Sahar Dadvand
DDS MS MSc
Endodontist
Dr. Amir Fakhrzadeh
DDS MS
Periodontist
Prof. Jim Gutmann
DDS MS MSc PhD
Endodontist
Dr. Ali M Saghiri
PhD
Computer Engineering
Dr. Kasra Momeni
PhD
Materials Science
Dr. Stephen B. Robie
PhD
X-Ray Crystallography
Dr. Fatereh Samadi
DDS MS
Orthodontist
Dr. Elham Samadi
DDS
Dentist
Dr. Ali Obeidi
DDS DMD MS
Prosthodontist
Dr. Peter Freag
DDS
Dentist
Dr. Ali Baghalian
DDS MS MSc
Pediatric Dentist
Dr. Armen Asatourian
DDS
Dentist
Dr. Michael Conte
DMD MPH
Senior Associate Dean for Clinical Affairs
Dr. Steven M. Morgano
DMD
Chair of the Department of Restorative Dentistry at RSDM
Legal Team
Dr. Saeid Amini
Esq PhD
Legal Consultant
347-921-3254
rootogen@gmail.com